IMC Chicago
ROIV icon

IMC Chicago’s Roivant Sciences ROIV Stock Holding History

IMC Chicago’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.63M Buy
102,600
+78,900
+333% +$2.33M ﹤0.01% 2435
2026
Q1 		$656K Sell
23,700
-419,800
-95% -$10.8M ﹤0.01% 3736
2025
Q4 		$9.62M Sell
443,500
-1,900
-0.4% -$37.5K ﹤0.01% 1251
2025
Q3 		$6.74M Buy
+445,400
New +$5.51M ﹤0.01% 1375

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

IMC Chicago's ROIV Position: Q2 2026 in Review

IMC Chicago increased its Roivant Sciences (ROIV) stake by 113% in Q2 2026, buying an estimated $1.08M and bringing the position to 68,630 shares worth $2.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2822.

IMC Chicago first reported a position in ROIV in Q1 2026 and has held it in 2 quarters since. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • IMC Chicago held 68,630 shares of Roivant Sciences worth $2.43M as of Q2 2026.
  • IMC Chicago bought 36,411 Roivant Sciences shares in Q2 2026, an estimated $1.08M.
  • Roivant Sciences made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #2822 holding.
  • IMC Chicago first reported a position in Roivant Sciences in Q1 2026 and has held it in 2 quarters since.
  • 499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.